Sugar Sweetened Beverages (SSB)- Effects on Metabolism

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01733563

Recruitment Status : Completed

First Posted : November 27, 2012

Last Update Posted : May 12, 2016

Sponsor:

Collaborators:

SNF Swiss National Foundation

University of Lausanne

Information provided by (Responsible Party):

University of Zurich

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	May 2016
Actual Study Completion Date :	May 2016

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Geidl-Flueck B, Hochuli M, Németh Á, Eberl A, Derron N, Köfeler HC, Tappy L, Berneis K, Spinas GA, Gerber PA. Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial. J Hepatol. 2021 Mar 6. pii: S0168-8278(21)00161-6. doi: 10.1016/j.jhep.2021.02.027. [Epub ahead of print]

To Top